http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011530519-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011530519-A |
| titleOfInvention | Method for treating or preventing hepatitis C using an immunomodulatory compound |
| abstract | The target is a compound of formula A, wherein n is 1 or 2, R is hydrogen, acyl, alkyl, or peptide fragment, and X is an aromatic or heterocyclic amino acid or derivative thereof: A therapeutic method for treating or preventing hepatitis C (HepC) in a target subject comprising administering an effective amount of an immunomodulatory compound of: (I) the immunomodulatory compound is administered to the subject at a dose greater than 0.001 mg / kg; (Ii) whether the immunomodulatory compound is administered in a combination therapy regimen further comprising administration of ribavirin to the subject, wherein the immunomodulatory compound and ribavirin are administered to the subject separately or together in the therapy regimen , (Iii) the immunomodulatory compound is administered in a combination therapy regimen with a specific targeted antiviral therapy (STAT-C) agent for hepatitis C, wherein the immunomodulatory compound and the STAT-C agent are the therapeutic regimen; Administered separately or together in the subject, or (Iv) A method is provided that is a combination of at least two of (i), (ii), and (iii). |
| priorityDate | 2008-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.